Access cutting-edge type 1 diabetes treatment through this clinical trial at a research site in Fresno. Study-provided care at no cost to qualified participants.
Access type 1 diabetes specialists in Fresno at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 1 diabetes treatment provided free
This study compares insulin icodec, an insulin taken once a week to insulin glargine, an insulin taken once a day. The study medicine will be investigated in participants with type 1 diabetes. The study will look at how well insulin icodec taken weekly controls blood sugar compared to insulin glargine taken daily. The study will last for about 8.5 months.
Sponsor: Novo Nordisk A/S
Check if you qualify for this type 1 diabetes clinical trial in Fresno, CA
If you're searching for type 1 diabetes treatment options in Fresno, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fresno research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 1 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.